Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Antioxidants and Redox Signaling

• Publication date

  2011-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/ars.2011.4078PMID 21644835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

  2011cited by this paper
• Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity

  2011cited by this paper
• Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy.

  2011cited by this paper
• Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1.

  2011influential reference
• Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.

  2010cited by this paper
• GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy

  2010cited by this paper
• The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

  2010cited by this paper
• Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.

  2010influential reference
• Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines

  2010cited by this paper
• A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells.

  2010cited by this paper
• Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor–Initiating Cells

  2010cited by this paper
• Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.

  2010cited by this paper
• Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.

  2010cited by this paper
• The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs

  2010cited by this paper
• A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

  2010cited by this paper
• Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

  2010cited by this paper
• Molecular mechanisms of necroptosis: an ordered cellular explosion

  2010cited by this paper
• Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II*

  2010cited by this paper
• α-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels

  2010cited by this paper
• Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo

  2010cited by this paper
• Metabolic Modulation of Glioblastoma with Dichloroacetate

  2010cited by this paper
• Mitochondria‐Penetrating Peptides: Sequence Effects and Model Cargo Transport

  2009cited by this paper
• Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications

  2009cited by this paper
• Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo

  2009cited by this paper
• Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.

  2009cited by this paper
• Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.

  2009cited by this paper
• An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

  2009cited by this paper
• Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy

  2009cited by this paper
• BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells

  2009cited by this paper
• The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia

  2009cited by this paper
• Resveratrol: Its Biologic Targets and Functional Activity

  2009cited by this paper
• Tumor resistance to apoptosis

  2009cited by this paper
• BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis.

  2009cited by this paper
• Targeting mitochondrial apoptosis by betulinic acid in human cancers.

  2009cited by this paper
• Ongoing phase I studies of ABT-263: Mitigating Bcl-XL induced thrombocytopenia with lead-in and continuous dosing.

  2009cited by this paper
• Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1

  2009cited by this paper
• Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling

  2008cited by this paper
• Measuring apoptosis at the single cell level.

  2008cited by this paper
• Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL.

  2008influential reference
• Mitochondria in cancer cells: what is so special about them?

  2008cited by this paper
• Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.

  2008cited by this paper
• A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

  2008cited by this paper
• Dichloroacetate (DCA) sensitizes both wild‐type and over expressing Bcl‐2 prostate cancer cells in vitro to radiation

  2008cited by this paper
• Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins

  2008cited by this paper
• Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.

  2008cited by this paper
• Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs

  2008cited by this paper
• Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.

  2008cited by this paper
• Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4*

  2008cited by this paper
• Development of mitochondria-targeted derivatives of resveratrol.

  2008cited by this paper
• BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells.

  2008cited by this paper
• The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.

  2008cited by this paper
• Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737.

  2008cited by this paper
• MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion.

  2008cited by this paper
• α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II

  2008cited by this paper
• ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis*

  2008cited by this paper
• In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

  2008cited by this paper
• Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program

  2008cited by this paper
• Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.

  2008cited by this paper
• Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model

  2008cited by this paper
• Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

  2008cited by this paper
• Dichloroacetate induces apoptosis in endometrial cancer cells.

  2008cited by this paper
• ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

  2008cited by this paper
• The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak.

  2007cited by this paper
• Methods for the assessment of mitochondrial membrane permeabilization in apoptosis

  2007cited by this paper
• Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

  2007cited by this paper
• Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.

  2007cited by this paper
• Translocation of proteins into mitochondria.

  2007cited by this paper
• Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics

  2007cited by this paper
• BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts

  2007cited by this paper
• Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma.

  2007cited by this paper
• Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer

  2007cited by this paper
• The Bcl-2 apoptotic switch in cancer development and therapy

  2007cited by this paper
• Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells

  2007cited by this paper
• An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone

  2007cited by this paper
• Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

  2007cited by this paper
• Bcl-2 family proteins are essential for platelet survival

  2007cited by this paper
• Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

  2007influential reference
• Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis

  2007cited by this paper
• 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.

  2007cited by this paper
• A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

  2007cited by this paper
• Mitochondrial membrane permeabilization in cell death.

  2007influential reference
• Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols

  2007cited by this paper
• Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

  2007cited by this paper
• Programmed anuclear cell death delimits platelet life span.

  2007cited by this paper
• Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress.

  2007cited by this paper
• Phase I trial of imexon in patients with advanced malignancy.

  2007cited by this paper
• Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.

  2006cited by this paper
• Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

  2006cited by this paper
• Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).

  2006cited by this paper
• Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

  2006cited by this paper
• Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario

  2006influential reference
• Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

  2006cited by this paper
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

  2006cited by this paper
• Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential.

  2006cited by this paper
• Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• ATP citrate lyase inhibition can suppress tumor cell growth.

  2005cited by this paper
• Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity.

  2005cited by this paper

• “Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”

  2025cites this paper
• Assessing the Efficacy of Mitochondria-Accumulating Self-Assembly Peptides in Pancreatic Cancer: An Animal Study

  2025cites this paper
• Molecular Docking of Natural Alkaloids with Bcl-xL Protein in The Apoptosis Process

  2024cites this paper
• The Anti-Melanoma Effect of Betulinic Acid Functionalized Gold Nanoparticles: A Mechanistic In Vitro Approach

  2022cites this paper
• Relationship between lifespan and somatic mutation in D. melanogaster after treatment with chlorophyllin.

  2022cites this paper
• Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance

  2021cites this paper
• The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma

  2021cites this paper
• Effective Synthesis of a Novel Betulinic Acid Conjugate with Mitochondria-Targeting Cation F16

  2021cites this paper
• Mitotropic Triphenylphosphonium Doxorubicin-Loaded Core-Shell Nanoparticles for Cellular and Mitochondrial Sequential Targeting of Breast Cancer.

  2021cites this paper
• Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria

  2021cites this paper
• Mitochondria-targeted prooxidant effects of betulinic acid conjugated with delocalized lipophilic cation F16.

  2021cites this paper
• Pentacyclic triterpene acid conjugated with mitochondria-targeting cation F16: Synthesis and evaluation of cytotoxic activities

  2021cites this paper
• Mitocanic Di- and Triterpenoid Rhodamine B Conjugates

  2020cites this paper
• Mitochondria-targeted 1,4-naphthoquinone (SkQN) is a powerful prooxidant and cytotoxic agent.

  2020cites this paper
• Design, Synthesis, and Photophysical Properties of BODIPY-Labeled Lupane Triterpenoids

  2020cites this paper
• Effect of betulin and betulonic acid on isolated rat liver mitochondria and liposomes.

  2020cites this paper
• The Contribution of Mitochondrial Ion Channels to Cancer Development and Progression.

  2019cites this paper
• Contribution of Mitochondrial Ion Channels to Chemo-Resistance in Cancer Cells

  2019cites this paper
• Cytotoxicity of 18 Cameroonian medicinal plants against drug sensitive and multi-factorial drug resistant cancer cells.

  2018cites this paper
• Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.

  2018cites this paper
• Cytotoxicity of seputhecarpan D, thonningiol and 12 other phytochemicals from African flora towards human carcinoma cells

  2018cites this paper
• Phenalenone‐photodynamic therapy induces apoptosis on human tumor cells mediated by caspase‐8 and p38‐MAPK activation

  2018cites this paper
• Mitochondrien als potenzielle Zielstruktur in der Krebstherapie

  2018influential citation
• Anticancerous Plant Compounds Affecting the Power House of Cancerous Cells: A Possible Herbal Mitocan

  2018cites this paper
• Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.

  2018cites this paper
• Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes.

  2017cites this paper
• Friend or foe? Mitochondria as a pharmacological target in cancer treatment.

  2017cites this paper
• Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets

  2017cites this paper
• Triphenylphosphonium cations of betulinic acid derivatives: synthesis and antitumor activity

  2017cites this paper
• Cytotoxicity of the coagulant Moringa oleifera lectin (cMoL) to B16-F10 melanoma cells.

  2017cites this paper
• The Natural Antiangiogenic Compound AD0157 Induces Caspase-Dependent Apoptosis in Human Myeloid Leukemia Cells

  2017cites this paper
• Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.

  2017cites this paper
• Mitochondria-targeted betulinic and ursolic acid derivatives: synthesis and anticancer activity

  2017cites this paper
• Mitochondrial association of MitoVES in MM cells was documented using its fluorescently tagged analogue. MitoVES caused apoptosis in MM cells by mitochondrial destabilization, resulting in the loss of mitochondrial membrane potential, generation of reactive oxygen species and destabilization of resp

  2017cites this paper
• Psorinum 6 × triggers apoptosis signals in human lung cancer cells.

  2016cites this paper
• Cytotoxicity of 15 Cameroonian medicinal plants against drug sensitive and multi-drug resistant cancer cells.

  2016cites this paper
• Mitochondria: An intriguing target for killing tumour-initiating cells.

  2016cites this paper
• Mechanism of cytotoxic activity of Canarium odontophyllum Miq. (dabai) against human colon cancer cell line HCT 116

  2016cites this paper
• Nano-encapsulated chlorophyllin significantly delays progression of lung cancer both in in vitro and in vivo models through activation of mitochondrial signaling cascades and drug-DNA interaction.

  2016cites this paper
• Adaptive mitochondrial reprogramming and resistance to PI3K therapy.

  2015cites this paper
• Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer.

  2015cites this paper
• Development and biochemical verification of a new method to isolate and quantify mitochondria from cell culture and liver tissue biopsies

  2015cites this paper
• Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells

  2015cites this paper
• Withaferin A-Caused Production of Intracellular Reactive Oxygen Species Modulates Apoptosis via PI3K/Akt and JNKinase in Rabbit Articular Chondrocytes

  2014cites this paper
• Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells

  2014cites this paper
• Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis

  2014cites this paper
• Reprogrammed metabolism of cancer cells as a potential therapeutic target.

  2014cites this paper
• Regulation of apoptosis induced by targeting the RAF/MEK/ERK pathway in human melanoma

  2014cites this paper
• Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy

  2014cites this paper
• Mitochondria in cancer: why mitochondria are a good target for cancer therapy.

  2014cites this paper
• Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.

  2014cites this paper
• Iron transport across the blood–brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy

  2014cites this paper
• Targeting cancer cell mitochondria as a therapeutic approach.

  2013cites this paper
• Synthesis, antiproliferative and mitochondrial impairment activities of bis-alkyl-amino transplatinum complexes.

  2013cites this paper
• Induction of human leukemia U937 cell apoptosis by an ethanol extract of Dendropanax morbifera Lev. through the caspase-dependent pathway.

  2013cites this paper
• p75NTR: an enhancer of fenretinide toxicity in neuroblastoma

  2013cites this paper
• Membrane Barriers for Bringing Drugs Inside Cells and Inside Cell

  2013cites this paper
• Genome-wide RNAi Screen Identifies Romo1 as a Novel Regulator of Mitochondrial Fusion and Cristae Integrity

  2013cites this paper
• Mitochondrial Reactive Oxygen Species in Proapoptotic Effect of Promising Cancer Chemopreventive Phytochemicals

  2013cites this paper
• Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy

  2013cites this paper
• Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro.

  2013cites this paper
• Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer Cells

  2013cites this paper
• BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I

  2013cites this paper
• Classification of mitocans, anti-cancer drugs acting on mitochondria.

  2013cites this paper
• Mitochondrial targeting overcomes ABCA1-dependent resistance of lung carcinoma to α-tocopheryl succinate

  2013cites this paper
• Mitochondrial complex II, a novel target for anti-cancer agents.

  2013cites this paper
• Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas

  2012cites this paper
• Implications of Altered Glutathione Metabolism in Aspirin-Induced Oxidative Stress and Mitochondrial Dysfunction in HepG2 Cells

  2012cites this paper
• Nullomer derived anticancer peptides (NulloPs): differential lethal effects on normal and cancer cells in vitro.

  2012cites this paper
• Novel Apoptotic Regulators in Carcinogenesis

  2012cites this paper
• Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance

  2012cites this paper
• Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo

  2012cites this paper